论文信息 - Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma - 字舞流文

Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma

G. Abou-Alfa | R. Kelley | A. El-Khoueiry | T. Meyer | L. Rimassa | Joong-Won Park | A. Cheng | H. Lim | J. Blanc | P. Merle | B. Ryoo | Ho Yeong Lim | E. Wang | A. Tran | P. McAdam | Yi-Wah Chan